The pharmacology of these two long-acting GLP-1 analogs, in terms of improving glycemic control, reducing body weight and decreasing cardiovascular (CV) risk, is also reviewed, together with some novel biology
The post hoc analysis of the SUSTAIN 6 trial revealed that once-weekly semaglutide reduced the risk of major adverse cardiovascular events in all subjects, regardless of gender, age, or baseline cardiovascular risk
Compounded tirzepatide from PlexusDx is $289 per month month-to-month, or from $249/mo on the 6-month plan for all dose strengths, with your dose adjusting as needed without affecting your monthly price
GHK-Cu studied for promoting visible scalp health and rejuvenation
Your doctor designs a personalised clinical-grade protocol, selecting the right medication (semaglutide, tirzepatide or an alternative), setting the starting dose and mapping out the titration schedule